vaccine against COVID-19
Covaxin maker Bharat Biotech, linked firms gave Rs 25 crore to TDP even though it is out of power
scroll.in/article/1065664/covaxin-maker-bharat-biotech-linked-firms-gave-rs-25-crore-to-tdp-even-though-it-is-out-of-power
Researchers from National Centre for Biological Sciences (NCBS) have in a study published in The Lancet Regional Health Southeast Asia on March 6 ... Show more #Covishield #Covaxin www.read.ht/SKX3
Japan's Takeda in regulatory talks to launch dengue vaccine in India: Japan's Takeda Pharmaceutical is holding talks with Indian regulators to make its dengue ...
reuters.com/business/healthcare-pharmaceuticals/japans-takeda-partners-with-indias-biological-e-boost-dengue-vaccine-production-2024-02-27/
#ProjectElectoralBond | Bharat Biotech, the manufacturer of Covaxin, donated Rs 25 crore to the TDP. The donations were made through #ElectoralBond and came at a time when the TDP is ... Show more @AnjanaMeenakshi
#ProjectElectoralBond | Bharat Biotech, the manufacturer of Covaxin, donated Rs 25 crore to the TDP. The donations were made through #ElectoralBonds and came ...
newslaundry.com/2024/03/22/covaxin-maker-bharat-biotech-gave-rs-25-crore-to-the-tdp-through-electoral-bonds
Shot stories: Meet Bharat Biotech's Krishna Ella, the man behind Covaxin: Covid 19 vaccine India: As the pandemic raged, India developed its own vaccine ...
business-standard.com/companies/interviews/shot-stories-meet-bharat-biotech-s-krishna-ella-the-man-behind-covaxin-123122201143_1.html
Paid articlePaid
Indian vaccine billionaire to pay £138mn for London mansion: Adar Poonawalla strikes biggest home sale of the year in UK capital with deal for Mayfair property
ft.com/content/235ad860-136e-46c2-bbbc-be0113a82f17
Indian ‘vaccine prince’ buys London townhouse for £138m: Price is second highest ever paid for a home in capital
thetimes.co.uk/article/adar-poonawalla-indian-vaccine-prince-buys-london-townhouse-for-138m-xhcp9sbk8
Paid articlePaid ‘The Vaccine War’ review: The real battle is elsewhere: Vivek Agnihotri’s film stars Nana Patekar, Pallavi Joshi and Raima Sen.
scroll.in/reel/1056625/the-vaccine-war-review-the-real-battle-is-elsewhere
Sudha Murty reacts after watching Vivek Agnihotri’s The Vaccine War: Vivek Agnihotri received praise for his film The Vaccine War depicting the development of ...
hindustantimes.com/entertainment/bollywood/sudha-murty-speech-the-vaccine-war-screening-vivek-agnihotri-film-101695103817373.html
‘The Vaccine War’ trailer: It’s scientists versus narratives in Vivek Agnihotri’s latest
thehindu.com/entertainment/movies/the-vaccine-war-trailer-its-scientists-versus-narratives-in-vivek-agnihotris-latest/article67302424.ece
The Vaccine War teaser: Vivek Agnihotri presents India’s first Bio-Science movie on creating Covaxin, film to clash with Salaar
indianexpress.com/article/entertainment/bollywood/the-vaccine-war-teaser-vivek-agnihotri-nana-patekar-india-first-bio-science-movie-covaxin-salaar-clash-8893144/
A new TB vaccine could save 8.5m lives over the next quarter of a century: But testing it will rely on the efforts of two charities
economist.com/science-and-technology/2023/06/28/a-new-tb-vaccine-could-save-85m-lives-over-the-next-quarter-of-a-century
Quick Glance: TB vaccine candidate in final trial, raising hopes of saving millions
- Efforts to end the tuberculosis pandemic may get a boost as a promising vaccine candidate secures funding for Phase III trials.
- The M72 vaccine could be the first new tuberculosis vaccine in a century if successful in the next trials and approved by regulators.
- Tuberculosis infected over 10 million people in 2021, mainly in low- and middle-income countries.
- Proof-of-concept trials showed that the M72 vaccine could prevent pulmonary disease in 54 percent of TB-infected adults.
General Atlantic, TA Associates in talks to invest in vaccine maker: VCCircle is India leading source Latest Indian Financial News,Startup Funding,Real Estate ...
vccircle.com/generalatlantic-ta-associates-in-talks-to-invest-in-vaccine-maker
India’s Success Is Based on the Strength of Its Private Sector and Massive Workforce
thediplomat.com/2023/06/indias-success-is-based-on-the-strength-of-its-private-sector-and-massive-workforce/
India’s Success Is Based on the Strength of Its Private Sector and Massive Workforce
thediplomat.com/2023/06/indias-success-is-based-on-the-strength-of-its-private-sector-and-massive-workforce/
Govt seeks three lakh doses of Covid vaccine: Patel admitted that currently there is “no” or “negligible” stock of vaccine available in the state ...
indianexpress.com/article/cities/gandhinagar/govt-seeks-three-lakh-doses-of-covid-vaccine-8540989/
Demand for affordable Indian generic Covid vaccines skyrocket in China: WHO issued a detailed document stating that the Indian vaccine against all variantrelated ...
business-standard.com/article/international/demand-for-affordable-indian-generic-covid-vaccines-skyrocket-in-china-123020400039_1.html
India’s first intranasal Covid vaccine inCOVACC launched: Clinical trials were conducted to evaluate iNCOVACC as a primary dose schedule and as a heterologous ...
indianexpress.com/article/india/india-first-intranasal-covid-vaccine-launched-8406234/
Booster dose of Covishield offers best immune response: Lancet study: A booster dose of Covishield offers the best immune response irrespective of whether the ...
business-standard.com/article/current-affairs/booster-dose-of-covishield-offers-best-immune-response-lancet-study-123012500769_1.html
SIIs Covid vaccine Covovax gets heterologous booster dose approval: Covovax can now be used as a heterologous booster dose for adults who have been administered ...
business-standard.com/article/current-affairs/sii-s-covid-vaccine-covovax-gets-heterologous-booster-dose-approval-123011700324_1.html
Bengaluru PHCs create 'microplans' to exhaust Covid doses: The BBMP’s primary healthcare centres (PHCs) are setting up Covid vaccination sites to use up their ...
deccanherald.com/city/top-bengaluru-stories/bengaluru-phcs-create-microplans-to-exhaust-covid-doses-1184295.html
Ocugen-Bharat Biotech COVID vaccine meets main goals in U.S. trial: Ocugen Inc (OCGN.O) said on Monday the COVID-19 vaccine developed by its Indian partner ...
reuters.com/business/healthcare-pharmaceuticals/ocugen-bharat-biotech-covid-vaccine-meets-main-goal-trial-2023-01-09/
Covishield immune responses against Covid variants higher than Covaxin: Study: The Omicron wave in early 2022 overlapped with the second dose of vaccine in two ...
financialexpress.com/lifestyle/health/covishield-immune-responses-against-covid-variants-higher-than-covaxin-study/2939739/
Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
deccanherald.com/national/govt-likely-to-float-global-tender-for-hpv-vaccine-in-april-merck-serum-institute-may-participate-1185671.html
India rolls out nasal vaccine as it prepares for rise in Covid-19 cases: NEW DELHI (The Straits Times/Asia News Network) India has rolled out a Covid-19 nasal ...
thestar.com.my/aseanplus/aseanplus-news/2022/12/29/india-rolls-out-nasal-vaccine-as-it-prepares-for-rise-in-covid-19-cases
Covishield immune responses against Covid-19 higher than Covaxin: Study: Neutralising antibody responses against the SARSCOV2 virus and its variants of concern ...
business-standard.com/article/current-affairs/covishield-immune-responses-against-covid-19-higher-than-covaxin-study-123010700378_1.html
Nasal vaccine gets nod for booster doses: The vaccine, iNCOVACC, will soon be available on the CoWin vaccination portal. The Drugs Controller General of India ...
financialexpress.com/lifestyle/health/nasal-vaccine-gets-nod-for-booster-doses/2925160/
Centre okays Bharat Biotech’s intranasal covid-19 vaccine | Mint: The vaccine can be administered to individuals who have received primary doses of Covaxin and ...
livemint.com/news/india/centre-okays-bharat-biotech-s-intranasal-covid-19-vaccine-11671820779315.html
Covishield and Corbevax stock over, BMC has only 6,000 Covaxin doses: The BMC data showed that only 13 per cent of the people have taken the booster or ...
indianexpress.com/article/cities/mumbai/covishield-and-corbevax-stock-over-bmc-has-only-6000-covaxin-doses-8341365/
Extremely serious procedural leniencies and incorrect reporting of the results of trials of Covaxin, Bharat Biotech’s anti-Covid vaccine, have come to light ... Show more #DC #DeccanChronicle #news #NewsUpdate #todaysnews #vaccine #Covid #covaxine https://www.deccanchronicle.com/nation/current-affairs/271122/bharat-biotech-misstated-covaxin-trial-data.html
Government Rubbishes Reports On Approval For Covaxin Due To Political Pressure: The Union Health Ministry today termed as "misleading" and ...
ndtv.com/india-news/government-rubbishes-reports-on-approval-for-covaxin-due-to-political-pressure-3528630
50 Million Doses Of Covaxin Set To Expire Early 2023: Report: Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are ...
ndtv.com/india-news/50-million-doses-of-covaxin-set-to-expire-early-2023-report-3494664
India vaccine maker destroys 100 million doses of expired Covid jab: Vaccine maker Serum Institute of India said the doses had expired due to falling demand.
bbc.com/news/world-asia-india-63324548
Bharat Biotech misstated Covaxin trial data: It raises questions on just how effective Covaxin was during the trials on developing antibodies in humans to help ...
deccanchronicle.com/nation/current-affairs/271122/bharat-biotech-misstated-covaxin-trial-data.html
Government junks claims of Covaxin approval due to political pressure: The Union Health Ministry, on Thursday, termed media reports which claimed that regulatory ...
deccanherald.com/national/government-junks-claims-of-covaxin-approval-due-to-political-pressure-1163175.html
Covaxin Was Rushed Under Political Pressure, Need for Speed: STAT Report: One of Bharat Biotech’s directors has admitted to skipping ‘mandatory’ steps in the ...
thewire.in/government/bharat-biotech-rushed-covaxin-political-pressure-stat
Covid vaccine: Around 5 cr doses of Covaxin to expire next year, report claims | Mint
livemint.com/news/india/around-50-mn-doses-of-covaxin-to-expire-in-early-2023-report-11667717559829.html
Poor Demand, Over 200 Million Covaxin Shots May Expire: Report: Even as we've seen multiple reports of Bharat Biotech's Covaxin being equally and sometimes even ...
india.com/business/poor-demand-over-200-million-covaxin-shots-may-expire-report-5722522/
India develops its first cervical cancer vaccine: The Serum Institute of India (SII), the world's biggest vaccine maker, has developed the country's first ...
reuters.com/business/healthcare-pharmaceuticals/india-develops-its-first-cervical-cancer-vaccine-2022-09-01/
CIC issues show-cause notice to CDSCO for denial of info on WHO’s suspension on Covaxin procurement
financialexpress.com/healthcare/cic-issues-show-cause-notice-to-cdsco-for-denial-of-info-on-whos-suspension-on-covaxin-procurement/2665270/
CorbeVax cleared as precaution dose vaccine, awaits WHO’s emergency use listing: This the first time that a booster dose that is different from the one used for ...
thehindu.com/sci-tech/health/corbevax-cleared-as-precaution-dose-vaccine-awaits-whos-emergency-use-listing/article65753569.ece
Paid articlePaid Cervical cancer vaccine a blessing: The approval by the Drugs Controller General of India of an indigenously developed vaccine, Cervavac, against cervical cancer ...
deccanherald.com/opinion/second-edit/cervical-cancer-vaccine-a-blessing-1143726.html
Exclusive: Covaxin’s Manufacturing Practices Remain ‘Unacceptable’ Says WHO: There is no ground to lift the suspension of the COVID-19 vaccine's procurement for ...
science.thewire.in/health/exclusive-covaxin-manufacturing-practice-remain-unacceptable-who/
Exclusive: During the first onsite inspection, the WHO had found 'quality issues' in the manufacturing of Covaxin at a Bharat Biotech facility in March ... Show more
Watch: WHO found 'Good Manufacturing Practices' violations at Bharat Biotech's Covaxin unit in March. The firm gave a corrective plan in June ... Show more
Monkeypox: ICMR invites bids to develop vaccine and diagnostic kits: This was announced after the National Institute of Virology said that it has successfully ...
scroll.in/latest/1029223/monkeypox-icmr-invites-bids-to-develop-vaccine-and-diagnostic-kits
Quick Glance: During the Monkeypox outbreak, the WHO advises gay and bisexual males to limit their sexual partners.
Covaxin booster dose safe, ensures persistent immunity to minimise breakthrough Covid infections: Study
indianexpress.com/article/india/covaxin-booster-dose-safe-persistent-immunity-covid-infections-study-8031755/
The Drugs Controller General of India (#DCGI ) approved India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against #cervical cancer
Full ... Show more https://bit.ly/3yF5Pcm
NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years
financialexpress.com/lifestyle/health/ntagi-panel-recommends-use-of-covid-vaccines-corbevax-covaxin-for-kids-aged-5-12-years/2587610/
Covid-19: Govt panel recommends Corbevax as booster for adults vaccinated with Covishield, Covaxin
financialexpress.com/lifestyle/health/covid-19-govt-panel-recommends-corbevax-as-booster-for-adults-vaccinated-with-covishield-covaxin/2614931/
Bharat Biotech expects DGCI’s nod for intranasal COVID-19 vaccine this month: Ella said the firm completed clinical trials of the nasal vaccine with about 4 ...
financialexpress.com/healthcare/covid-19/bharat-biotech-expects-dgcis-nod-for-intranasal-covid-19-vaccine-this-month/2614553/
The TRIPs waiver and India: A misadventure and a compromise in Geneva by the government
scroll.in/article/1027163/the-trips-waiver-and-india-a-misadventure-and-a-compromise-in-geneva-by-the-government
COVID-19 | Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study
thehindu.com/sci-tech/health/covid-19-covaxin-booster-dose-enhances-vaccine-effectiveness-against-delta-omicron-variants-says-icmr-study/article65529333.ece
India has crossed record 200 crore mark in Covid-19 vaccinations within 18 months of launching the inoculation exercise in January last year ... Show more #India #Covid #Vaccinations #BharatBiotech #SerumInstitute #Covaxin #Covishield #Pfizer #Moderna #2crorevaccines #Firstpost
Free COVID Booster Dose Only At Govt Facilities; Pay Rs 400 At Private Hospitals, Centres | Details Here
india.com/news/india/utility-news-vaccine-free-covid-booster-dose-only-at-govt-facilities-pay-rs-400-at-private-hospitals-centres-details-here-5516691/
Vaccination advisory group recommends reducing COVID-19 booster dose gap to 6 months
thehindu.com/sci-tech/health/ntagi-recommends-reducing-covid-booster-dose-gap-to-6-months/article65534281.ece
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat Biotech
thehindu.com/news/national/covaxin-demonstrates-robust-safety-and-immunogenicity-in-children-2-18-years-bharat-biotech/article65536897.ece
Covaxin safe, immunogenic in those aged 2-18: Lancet study: Bharat Biotech International Limited (BBIL) on Friday announced that its Covid-19 vaccine Covaxin has ...
deccanherald.com/science-and-environment/covaxin-safe-immunogenic-in-those-aged-2-18-lancet-study-1118948.html
Paraguay to cancel contract with Bharat Biotech for Covaxin over quality issues: The contract was put together with the help of Taiwan, which has close ties with ...
hindustantimes.com/india-news/paraguay-to-cancel-contract-with-bharat-biotech-for-covaxin-over-quality-control-issues-101654600507229.html
The #NTAGI panel also reviewed data on Covaxin and Corbevax vaccines for the 6-12 age group. #COVIDVaccination #CoronaVaccine
India’s drugs regulator has approved #Corbevax as the first mix-and-match #BoosterDose for adults, the company said in a statement
Read more https://bit.ly/3ziIi35
As Corona Cases Surge, Govt Advisory Body Recommends Reducing Gap Between Second & Precaution Dose
india.com/news/india/corona-cases-surge-govt-advisory-body-recommends-reducing-gap-between-second-and-precaution-dose-covid-19-vaccine-ntagi-4th-wave-booster-dose-health-ministry-latest-update-5457809/
Germany Recognises Bharat Biotech’s Covaxin For Travel Purposes. Here’s What It Means For Indians
india.com/news/world/international-travel-latest-update-26-may-2022-germany-recognises-bharat-biotechs-covaxin-for-travel-purpose-heres-what-it-means-for-indians-check-details-5415058/
Biological E Seeks Approval Of Corbevax As Booster For Covishield, Covaxin Recipients | Mint
livemint.com/news/india/biological-e-seeks-approval-of-corbevax-as-booster-for-covishield-covaxin-recipients-11652276148159.html
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics